Searched for
RECURSION PHARMACEUTICALS
Illumina launches dataset to speed up AI-powered drug discoveryIllumina has introduced a new dataset to speed up drug discovery using artificial intelligence. This initiative involves major drugmakers l...- US stock futures jump today: Dow, S&P 500, Nasdaq turn green ahead of key economic data and holiday-thinned tradingUS stock futures jump today as Dow futures, S&P 500 futures, and Nasdaq futures turn green early Tuesday. Investors position ahead of key e...
- US stock futures surge today: Dow, S&P 500, Nasdaq turn green ahead of CPI inflation data - Micron revives Nvidia, TeslaUS stock futures rose Thursday as investors awaited key CPI inflation data. Nasdaq futures led gains, supported by Micron’s strong AI-drive...
- Nasdaq crashes today: Why Nasdaq is down today - Nasdaq Composite slides 1.1% as Nvidia, Tesla, Oracle lead tech selloffNasdaq crashes today as tech stocks retreat sharply. The Nasdaq Composite slides 1.1% in midday trade. Nvidia drops nearly 3% on heavy sell...
- AI-driven drug discovery picks up as FDA pushes to reduce animal testingDrug development software maker Certara, and biotechs such as Schrodinger and Recursion Pharmaceuticals are already using AI to predict how...
- U.S. stock market futures dip slightly today — is this the calm before the Big Tech earnings storm as Wall Street awaits Tesla, Microsoft, and Alphabet results?U.S. stock market futures are treading water this morning as investors wait for major earnings from Microsoft, Tesla, and Alphabet. After a...
- Jensen Huang's Valentine's Day bomb: Investors in shock as Nvidia buys and dumps AI stocks in stunning power playNvidia CEO Jensen Huang revealed the company's AI portfolio on February 14. Nvidia divested its holdings in SoundHound AI, Serve Robotics, ...
- Lure of diversification, higher returns and global exposure driving Indian investors to US markets: Subho MoulikSubho Moulik, CEO of Appreciate, explains the increased interest of Indian investors in US markets, emphasizing diversification, higher ret...
- Mubadala plans big deals in India's healthcare spaceAbu Dhabi's Mubadala Investment Company plans to expand in India's healthcare sector, seeking deals in the $200-500 million range. With a f...
- AI firms surge after chip giant Nvidia discloses stakeShares of biotech firm Recursion Pharmaceuticals, in which Nvidia invested nearly $76 million, gained 5%. Last year, Nvidia had said it wou...
- AI firms surge after chip giant Nvidia discloses stakeThe rally showed Nvidia's growing influence in the AI world as its market value grows at a scorching pace, making it the third most-valuabl...
- Recursion Pharmaceuticals expands IPO to raise $436 millionThe Salt Lake City-based company sold about 24 million shares on Thursday for $18 each, according to data compiled by Bloomberg. The compan...
Load More
